Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 9th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany Recently, a patient said goodbye to me with the words: “If we are not successful with the culture, then I want the genetic test. My health insurance […]
Since end of 2020, different SARS-CoV-2 variants have appeared worldwide − alpha (B.1.1.7), beta (B.1.351), gamma (P.1/B.1.1.128) and delta (B1.617.2) − which are in part more contagious than the original virus type and are therefore spreading more quickly within populations. These variants reveal genetic changes (mutations) in the so-called receptor binding domain (RBD), which is
Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 8th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany “The Times They Are a-Changin” is one of the best known songs from Bob Dylan, a winner of the Nobel Prize for Literature. As frequently acknowledged, the
Six months after the start of the COVID-19 vaccination campaign in Germany, half of the population has received at least one vaccination dose. According to the Federal Ministry of Health, 37.9% of them have already been fully vaccinated (as of 02.07.2021). Currently there are four different COVID-19 vaccines available in Germany, which differ slightly in
Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 7th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany This pathogen’s discovery was a complete coincidence. In 1989, I had a teaching assignment at the medical faculty in Luanda, where I was supposed to teach medical
